Trial of DMXB-A in Schizophrenia

  Trial of DMXB-A in Schizophrenia     Summarize the drug, MOA, study design, with the inclusion and exclusion criteria. What percent of patients (approximately) of the total affected with this disease would be eligible to be treated? If the population studied in the trial are the only patients eligible for treatment when the drug is approved, what percent (approximately) would not be able to take this medication? Discuss the restrictions to the target population, and any other special circumstances for either including or excluding sub groups of patients and include your rationale